Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies and Perspectives
Inflammatory bowel diseases (IBDs) represent a category of diseases characterized by intestinal inflammation and include two main entities, ulcerative colitis and Crohn’s disease, one of the representative clinical characteristics of which being chronic diarrhea. The etiology of these diseases is mu...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84833 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies and Perspectives
- Gut Microbiota and Inflammatory Bowel Disease
- The Gut Microbiota as Target for Innovative Drug Development: Perspectives and a Case Study of Inflammatory Bowel Diseases
- First Middle Eastern-Based Gut Microbiota Study: Implications for Inflammatory Bowel Disease Microbiota-Based Therapies
- Inflammatory Bowel Disease Biomarkers of Human Gut Microbiota Selected via Ensemble Feature Selection Methods
- Current Elective Surgical Treatment of Inflammatory Bowel Disease
- Current and Future Biological Treatments in Inflammatory Bowel Disease